➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: September 22, 2021

DrugPatentWatch Database Preview

Details for Patent: 6,152,897

Email this page to a colleague

« Back to Dashboard

Summary for Patent: 6,152,897
Title: Syringe
Abstract:The invention relates to a one-dose syringe comprising a first chamber with a freeze-dried composition comprising a protein in an amount of less than 1.4 mg, amino acid and stabilizer where the weight ratio between protein and amino acid versus stabilizer is less than 1.5 and in which the ratio of the weight of the dry component versus the cake volume in the first chamber is above 12 mg/ml, and a second chamber with an aqueous reconstitution solution with an injectable volume of less than 0.5 ml.
Inventor(s): Limrell; Karin (Sollentuna, SE), Florin-Robertsson; Ebba (Stockholm, SE), Hokby; Elvy (Enskede, SE), Nilsson; Ulf (Ekero, SE), Strom; Anders (Enskede, SE)
Assignee: Pharmacia & Upjohn AB (Stockholm, SE)
Application Number:09/196,514
Patent Claim Types:
see list of patent claims
Composition; Formulation;

Drugs Protected by US Patent 6,152,897

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,152,897

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden9704405Nov 28, 1997

International Family Members for US Patent 6,152,897

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 354390 ⤷  Free Forever Trial
Australia 1356699 ⤷  Free Forever Trial
Australia 742494 ⤷  Free Forever Trial
Canada 2311754 ⤷  Free Forever Trial
China 1156315 ⤷  Free Forever Trial
China 1280511 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.